InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Keros Therapeutics, Inc.

KROS Clue Score64
United States Fiscal year ends December CIK 0001664710
$11.95 +2.66% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $11.95 −69.11% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 8 Apr 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue10.0Operating income−10.6Net income−12.3Fiscal year 2020Revenue0.0 −100.0%Operating income−46.7Net income−45.4EPS, diluted−2.93Fiscal year 2021Revenue20.1Operating income−56.4Net income−58.7EPS, diluted−2.52Fiscal year 2022Revenue0.0 −100.0%Operating income−114.8Net income−104.7EPS, diluted−4.15Fiscal year 2023Revenue0.2Operating income−169.9Net income−153.0EPS, diluted−5.20Fiscal year 2024Revenue3.6 +2,251.0%Operating income−210.8Net income−187.4EPS, diluted−5.00Fiscal year 2025Revenue244.1 +6,775.0%Operating income67.6Net income87.0EPS, diluted2.30
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 10.0 0.0 20.1 0.0 0.2 3.6 244.1
Growth −100.0% −100.0% +2,251.0% +6,775.0%
Operating income −10.6 −46.7 −56.4 −114.8 −169.9 −210.8 67.6
Net income −12.3 −45.4 −58.7 −104.7 −153.0 −187.4 87.0
Growth
EPS, diluted n/a −2.93 −2.52 −4.15 −5.20 −5.00 2.30

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2019Operating margin−105.6%Net margin−123.4%Free cash flow margin−162.7%Fiscal year 2020Fiscal year 2021Operating margin−280.5%Net margin−292.3%Free cash flow margin−314.3%Fiscal year 2022Fiscal year 2023Operating margin−112,543.7%Net margin−101,319.2%Free cash flow margin−84,087.4%Fiscal year 2024Operating margin−5,939.0%Net margin−5,277.5%Free cash flow margin−4,585.9%Fiscal year 2025Operating margin27.7%Net margin35.7%Free cash flow margin43.4%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −105.6% n/a −280.5% n/a −112,543.7% −5,939.0% 27.7%
Net margin −123.4% n/a −292.3% n/a −101,319.2% −5,277.5% 35.7%
Free cash flow margin −162.7% n/a −314.3% n/a −84,087.4% −4,585.9% 43.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−16.0Capital expenditure−0.3Free cash flow−16.3Fiscal year 2020Operating cash flow−36.9Capital expenditure−0.3Free cash flow−37.2Fiscal year 2021Operating cash flow−62.1Capital expenditure−1.0Free cash flow−63.2Fiscal year 2022Operating cash flow−70.1Capital expenditure−1.2Free cash flow−71.3Fiscal year 2023Operating cash flow−124.5Capital expenditure−2.5Free cash flow−127.0Fiscal year 2024Operating cash flow−160.9Capital expenditure−1.9Free cash flow−162.8Buybacks0.0Fiscal year 2025Operating cash flow107.5Capital expenditure−1.6Free cash flow106.0Buybacks−375.0
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −16.0 −36.9 −62.1 −70.1 −124.5 −160.9 107.5
Capital expenditure −0.3 −0.3 −1.0 −1.2 −2.5 −1.9 −1.6
Free cash flow −16.3 −37.2 −63.2 −71.3 −127.0 −162.8 106.0
Growth
Buybacks n/a n/a n/a n/a n/a 0.0 −375.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2019Cash7.0Shareholders’ equity−19.4Fiscal year 2020Cash265.9Shareholders’ equity261.7Fiscal year 2021Cash230.0Shareholders’ equity243.2Fiscal year 2022Cash279.0Shareholders’ equity277.4Fiscal year 2023Cash331.1Shareholders’ equity332.2Fiscal year 2024Cash559.9Shareholders’ equity571.6Fiscal year 2025Cash287.4Shareholders’ equity303.1
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 7.0 265.9 230.0 279.0 331.1 559.9 287.4
Shareholders’ equity −19.4 261.7 243.2 277.4 332.2 571.6 303.1

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
10.0 0.0 20.1 0.0 0.2 3.6 244.1
Growth −100.0% −100.0% +2,251.0% +6,775.0%
17.4 33.9 55.1 87.3 135.3 173.6 129.6
3.2 12.8 21.3 27.5 34.8 40.8 46.8
−10.6 −46.7 −56.4 −114.8 −169.9 −210.8 67.6
Growth
−12.3 −45.5 −56.7 −104.7 −153.0 −187.1 91.9
0.0 −0.2 2.0 0.0 0.0 0.3 4.9
−12.3 −45.4 −58.7 −104.7 −153.0 −187.4 87.0
Growth
Per share
n/a −2.93 −2.52 −4.15 −5.20 −5.00 2.34
n/a −2.93 −2.52 −4.15 −5.20 −5.00 2.30
Growth
n/a 15.5 23.3 25.2 29.4 37.4 37.2
n/a 15.5 23.3 25.2 29.4 37.4 37.9
Growth +50.5% +8.2% +16.7% +27.1% +1.1%

† The diluted share count jumps at 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 6 of 7 years on file.